Assenagon Asset Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-653
| Closed | -$13.8K | – | 1438 |
|
|
2023
Q2 | $13.8K | Buy |
+653
| New | +$13.8K | ﹤0.01% | 1270 |
|
|
2023
Q1 | – | Sell |
-21,092
| Closed | -$747K | – | 1480 |
|
|
2022
Q4 | $747K | Buy |
21,092
+613
| +3% | +$21.7K | ﹤0.01% | 1055 |
|
|
2022
Q3 | $4.63M | Sell |
20,479
-759
| -4% | -$171K | 0.02% | 483 |
|
|
2022
Q2 | $4.01M | Buy |
21,238
+873
| +4% | +$165K | 0.01% | 586 |
|
|
2022
Q1 | $5.07M | Buy |
20,365
+12,914
| +173% | +$3.22M | 0.01% | 501 |
|
|
2021
Q4 | $1.16M | Buy |
+7,451
| New | +$1.16M | ﹤0.01% | 948 |
|
|
2021
Q2 | – | Sell |
-13,057
| Closed | -$3.47M | – | 1408 |
|
|
2021
Q1 | $3.47M | Sell |
13,057
-5,449
| -29% | -$1.45M | 0.01% | 557 |
|
|
2020
Q4 | $6.82M | Hold |
18,506
| – | – | 0.03% | 276 |
|
|
2020
Q3 | $4.52M | Buy |
18,506
+16,314
| +744% | +$3.98M | 0.03% | 322 |
|
|
2020
Q2 | $631K | Buy |
+2,192
| New | +$631K | ﹤0.01% | 909 |
|
|
2019
Q3 | – | Sell |
-14,806
| Closed | -$4.71M | – | 1078 |
|
|
2019
Q2 | $4.71M | Buy |
+14,806
| New | +$4.71M | 0.04% | 266 |
|